OncoQuest Pharmaceuticals Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 121

Employees

  • Stock Symbol
  • 078590

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $0.37
  • (As of Friday Closing)

OncoQuest Pharmaceuticals General Information

Description

Hyulim A Tech Co Ltd, formerly DIAC Co Ltd is a Korea-based company engaged in the manufacturing of carpets for automobiles. It mainly provides car interior carpet products such as car seat fabrics, car seat coverings, car seat moldings and airbags used for passenger cars and recreational vehicles. The company also involves in the production of interior fabrics, sofa fabrics, and others.

Contact Information

Website
www.oqp.co.kr
Formerly Known As
Duol Industrial Co., Ltd., Hyulim A Tech, Diac
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4th Floor, 445 Teheran-Ro
  • Gangnam-Gu
  • Seoul, 50414
  • South Korea
+82
Primary Industry
Automotive
Stock Exchange
KRX
Vertical(s)
Manufacturing, Industrials
Corporate Office
  • 4th Floor, 445 Teheran-Ro
  • Gangnam-Gu
  • Seoul, 50414
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoQuest Pharmaceuticals Stock Performance

As of 13-Dec-2024, OncoQuest Pharmaceuticals’s stock price is $0.37. Its current market cap is $19.8M with 53.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.37 $0.37 $0.34 - $1.27 $19.8M 53.7M 808K

OncoQuest Pharmaceuticals Financials Summary

As of 30-Sep-2024, OncoQuest Pharmaceuticals has a trailing 12-month revenue of $57.6M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 23,416 38,323
Revenue 57,632 48,693 33,696 37,200
EBITDA 5,871 7,482 8,661 (3,345)
Net Income 4,477 6,273 7,533 (75,645)
Total Assets 41,795 42,052 34,858 26,063
Total Debt 888 453 2,449 4,941
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OncoQuest Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OncoQuest Pharmaceuticals‘s full profile, request access.

Request a free trial

OncoQuest Pharmaceuticals Patents

OncoQuest Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021084904-A Insect proof material Pending 29-Nov-2019
US-20200206347-A9 Method of indirect immunization of human ovarian cancer patients through selection of xenogeneic immunoglobulin fc portions Inactive 06-Feb-2017
EP-3357509-B1 Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant Active 06-Feb-2017
EP-3357509-A1 Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant Active 06-Feb-2017
JP-2018042729-A Display tool for rail Pending 14-Sep-2016
To view OncoQuest Pharmaceuticals’s complete patent history, request access »

OncoQuest Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoQuest Pharmaceuticals Investments & Acquisitions (5)

OncoQuest Pharmaceuticals’s most recent deal was a Merger/Acquisition with Canaria Bio (Asan Plant Business) for . The deal was made on 13-Sep-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Canaria Bio (Asan Plant Business) 13-Sep-2023 Merger/Acquisition Pharmaceuticals
OncoQuest (Clinical & Pre-clinical Immunotherapy Development Assets) 17-Nov-2020 Corporate Asset Purchase Buildings and Property
J.Technology 08-Apr-2019 Merger/Acquisition Distributors/Wholesale
Borgstena 01-Sep-2017 Merger/Acquisition Synthetic Textiles
OncoQuest Merger/Acquisition Biotechnology
To view OncoQuest Pharmaceuticals’s complete investments and acquisitions history, request access »

OncoQuest Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
Borgstena Synthetic Textiles Nelas, Portugal
To view OncoQuest Pharmaceuticals’s complete subsidiaries history, request access »

OncoQuest Pharmaceuticals FAQs

  • When was OncoQuest Pharmaceuticals founded?

    OncoQuest Pharmaceuticals was founded in 1993.

  • Where is OncoQuest Pharmaceuticals headquartered?

    OncoQuest Pharmaceuticals is headquartered in Seoul, South Korea.

  • What is the size of OncoQuest Pharmaceuticals?

    OncoQuest Pharmaceuticals has 121 total employees.

  • What industry is OncoQuest Pharmaceuticals in?

    OncoQuest Pharmaceuticals’s primary industry is Automotive.

  • Is OncoQuest Pharmaceuticals a private or public company?

    OncoQuest Pharmaceuticals is a Public company.

  • What is OncoQuest Pharmaceuticals’s stock symbol?

    The ticker symbol for OncoQuest Pharmaceuticals is 078590.

  • What is the current stock price of OncoQuest Pharmaceuticals?

    As of 13-Dec-2024 the stock price of OncoQuest Pharmaceuticals is $0.37.

  • What is the current market cap of OncoQuest Pharmaceuticals?

    The current market capitalization of OncoQuest Pharmaceuticals is $19.8M.

  • What is OncoQuest Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for OncoQuest Pharmaceuticals is $57.6M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »